Industry Group Chat at BIO US
BIO US made one thing clear: sponsors, CROs, and service providers are done accepting "complicated" as an excuse in clinical trial management.
Representing Tanner Pharma Group's Clinical Trial Solutions team, Lisa Fotheringham and Rory Williams talked with sponsors, CROs, and service providers about where clinical trial operations are headed. The takeaway: everyone wants more efficiency, more flexibility, and better alignment across global trial ecosystems, now.
Pharmacy manuals are becoming operational tools. No longer static binders, they're living documents supporting execution and compliance throughout a trial.
Patient-centricity is now an operating model. It's shaping clinical supply chain decisions and comparator sourcing, not just messaging.
Sponsor-CRO partnerships are getting strategic. Comparator sourcing and clinical supply management are moving from procurement afterthoughts to strategic vendor relationships built for flexibility across geographies and regulations.
Packaging, labeling, and investigator-sponsored trials are getting more complex. Automation and integrated content management for clinical labeling are helping teams stay consistent and compliant across markets.
Bottom line: clinical trial services are mid-shift. The organizations that align people, processes, and technology, while collaborating closely across stakeholders, will move fastest.
At Tanner Pharma Group, we help biopharmaceutical companies turn that momentum into results through flexible Clinical Trial Solutions and collaborative delivery models built for successful trial execution.
Ready to talk about your next clinical trial? Let's connect.
